We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Braun, B.

Supplies products for anesthesia, intensive medicine, cardiology, extra corporeal blood treatment and surgery, as wel... read more Featured Products: More products

Download Mobile App




Novel Luer Access Device to Reduce Hospital-Acquired Bloodstream Infections

By HospiMedica International staff writers
Posted on 21 Dec 2023

Hospital-acquired bloodstream infections (HA-BSIs), which are generally associated with catheter insertions, are a primary cause of morbidity and mortality. More...

Now, a neutral displacement Luer access device has been designed to reduce exposure to harmful chemicals and minimize infection risk, making IV access safer for patients and healthcare providers.

B. Braun Medical (Bethlehem, PA, USA) has launched its new CARESITE Micro Luer Access Device featuring the first and only neutral needleless connector not made with Bisphenol A (BPA), a harmful chemical that causes multi-organ toxicity. The CARESITE Micro Device is manufactured using a drug-resistant material which can help lower the risk of infections and drug exposure as a result of stress cracks related to material and drug incompatibility. The CARESITE Micro Device has a smooth, flat surface that enables proper disinfection, and features a straight fluid path design that helps achieve flushing of blood and medications using a small flush volume, thereby reducing the risk of HA-BSI.

"We are excited to introduce the CARESITE Micro Luer Access Device. Helping to reduce HA-BSIs and accidental drug exposure supports our commitment to the safety of the patients and providers we serve," said Angela Karpf, MD, Corporate Vice President, Medical Affairs.

Related Links:
B. Braun Medical 


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
Spirometry & Oximetry Software
MIR Spiro
Autoclave
Advance
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.